
Comprehensively mapping and decoding the immune system with single-cell biology and AI to power new therapeutic discoveries, accelerate drug development and improve patient outcomes

Comprehensively mapping and decoding the immune system with single-cell biology and AI to power new therapeutic discoveries, accelerate drug development and improve patient outcomes
Founded: December 2018
Headquarters: New York, NY
Core offering: Single-cell multiomic immune mapping + ML platform (AMICA) for therapeutic discovery
Total funding: USD 295,000,000
| Company |
|---|
Immune system mapping to improve discovery and development of immunology and oncology therapeutics.
2018
Biotechnology Research
USD 20,000,000
USD 60,000,000
Raised to expand annotated multi-omic immune cell atlas; reported total after round > USD 80M
USD 215,000,000
Brought reported total funding to USD 295M
“Includes strategic and institutional investors such as Schusterman Family Investments, Catalio Capital Management, Viola/TLV, Piedmont Capital Investments, and Alexandria Venture Investments.”
About Immunai
Immunai is an engineering-first platform company aiming to improve therapeutic decision-making throughout the drug discovery and development process. We are mapping the immune system at unprecedented scale and granularity and applying machine learning to this massive clinico-immune database, in order to generate novel insights into disease pathology for our partners - pharma companies and research institutes. We provide a comprehensive, end-to-end solution - from data generation and curation to therapeutics development, that continuously supports and validates the capabilities of our platform.
As drug development is becoming increasingly inefficient, our ultimate goal is to help bring breakthrough medicines to patients as quickly and successfully as possible.
Immunai is an equal opportunity employer. We celebrate diversity and are committed to creating an inclusive environment for all employees.
About the role
As the Product Manager for the AI models of Immunai's core product offering, you will be responsible for defining and driving its product strategy, requirements, roadmap and delivery.
The product focuses on addressing real-world challenges in drug development by leveraging AI foundation models and multi-omic data to map and predict human immune response.
You will be working closely with our team of Data Scientists, Computational Biologists, Deep Learning Researchers and Engineers.
Location: Ramat Gan, Israel (Hybrid model)
What will you do?
Required qualifications
Desired personal traits
*When you apply for a role at Immunai, we process your personal data (such as CV, contact details, and professional background) to assess your suitability for current and future roles. Your information may be shared internally with relevant employees and stored or processed by trusted service providers, some of whom may be located outside your country of residence. You can read more about how we process data here: https://www.immunai.com/privacy-policy/ .